RenalGuard Solutions

RenalGuard is focused on developing innovative technologies for the #vascular markets and committed to #AKI prevention.

[RenalGuard Solutions @RenalGuard]

KIDNEY Clinical Trial Results:
RenalGuard Therapy ® Prevents Acute Kidney Injury after Cardiac Surgery. Read more at https://t.co/brYsvqolRx. #RenalGuard #ActiveKidneyProtection #ContrastInducedNephropathy #RenalGuardTherapy #cardiacsurgery #PreventAKI

[RenalGuard Solutions @RenalGuard]

RenalGuard Therapy Prevents Acute Kidney Injury after Cardiac Surgery https://t.co/Tm53Piz4Ww

[RenalGuard Solutions @RenalGuard]

NNT: 9 patients; the number needed to treat with #RenalGuard automated diuresis to help prevent #cardiacsurgery-associatedAKI #ASN #kidneywk

[RenalGuard Solutions @RenalGuard]

#KIDNEY trial: #RenalGuard automated diuresis significantly reduces #AKI after #cardiac surgery. #Post-opAKI significantly lower in RenalGuard group vs. standard hydration, 10% vs. 20.9%. #ASN #kidneywk

[RenalGuard Solutions @RenalGuard]

Late-breaking #KIDNEY #clintrial results this morning at 10:00, Exhibit Halls/AB. #AKI prevalent in cardiac surgery, occurring in 30 percent of cases and 50-70 percent of emergent cases. Can it be reduced? Poster TH-PO1183. #ASN #kidneywk

[RenalGuard Solutions @RenalGuard]

Hope to see you tomorrow 10:00 am; #latebreaking #clintrial TH-PO1183. Kidney protection using the #RenalGuard System in Cardiac Surgery (KIDNEY Study)…assessing #AKI rates; randomized controlled 220-patient trial. #ASN #kidneywk

[RenalGuard Solutions @RenalGuard]

#Cardiac surgery with less #AKI? Late-breaking presentation: #KIDNEY trial results tomorrow @ASN 10:00 am. Promising #RenalGuard automated diuresis medtech. #ASN #kidneywk

[RenalGuard Solutions @RenalGuard]

Late Breaking Clinical Trial Results from TCT!

https://t.co/AENUOTBkbp

[RenalGuard Solutions @RenalGuard]

Late-Breaking REMEDIAL III Clinical Trial Presented at TCT Shows RenalGuard Therapy's Automated, Personalized Hydr... https://t.co/wve2btTY5d

[C. Michael Gibson MD @CMichaelGibson]

Watch my interview with Dr. Carlo Briguori where he explains the results of REMEDIAL III presented at #TCT2019.

https://t.co/GC3Vngik4M

[C. Michael Gibson MD @CMichaelGibson]

REMEDIAL III slides presented at #TCT2019 outlining a randomized trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration. UFR-guided approach is superior in preventing CI-AKI in high-risk patients.

Full slide deck: https://t.co/sHG3Dr8l1l

[RenalGuard Solutions @RenalGuard]

Latest podcast by @medtechconf featuring Jim Dillon, CEO, @ReprieveCardio and @RenalGuard https://t.co/SI12Ijy4Ds …
#heartfailure #reprievecardio #renalguard

[RenalGuard Solutions @RenalGuard]

Prof. Ponikowski explains why his late-breaking results from ESC-HF make him optimistic about the potential for @RenalGuard system to help decongest heart failure patients w/ fluid overload. #ADHF #heartfailure https://t.co/YlV1WVTJDX

[RenalGuard Solutions @RenalGuard]

Watch how RenalGuard-Guided Diuretic Therapy is is designed to work for #heartfailure and #AKI patients in our animation video here. #HeartFailure2018
https://t.co/cXVjqOhacJ

[RenalGuard Solutions @RenalGuard]

We presented #latebreaking data at @escardio #HeartFailure2018 that demonstrated potential benefits of RenalGuard-Guided Diuretic Therapy for #heartfailure. Check out the press release for full details here. https://t.co/lS5VxaN2Uc

[RenalGuard Solutions @RenalGuard]

We’re excited to announce #RenalGuard is being used for kidney protection in a live case at @OptimalCTO by Dr. Javier Escaned. #CTOCONF18

[MassDevice @MassDevice]

RenalGuard touts ADHF treatment feasibility study data https://t.co/tOb2LEBJ3X #meddevice

[CardiacVascularNews @CardiacVascNews]

New Study Demonstrates Feasibility of Using RenalGuard-Guided Diuretic Therapy f https://t.co/famFybEom1

[Worcester Business Journal @WBJournal]

The device, the RenalGuard-Guided Diuretic Therapy, was proven to optimize fluid management in acute decompensated heart failure patients while alleviating related symptoms.

https://t.co/NWSCo9FBJw

[Coghlin Companies @coghlin_cos]

Cogmedix is proud to have a long standing relationship with RenalGuard Solutions, working with them to manufacture their critical life-saving #MedicalDevices Congratulations to RenalGuard for their recent clinical trial success! https://t.co/EMyqm1wc4x